PheWAS of a Polygenic Predictor of Thyroid Function

CompletedOBSERVATIONAL
Enrollment

37,154

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions
ThyroidGenetic Predisposition to Disease
Interventions
GENETIC

phenome-wide association study (PheWAS)

Phenome-wide association study (PheWAS) identifying clinical diagnoses associated with a polygenic predictor of TSH levels identified by a previously published genome-wide association study (GWAS) which included North American and European participants. A phenome-wide scanning of 1,318 phenotypes will be performed, using a cohort of 37,154 North American individuals of European ancestry with electronic-health-record (EHR) data.

Trial Locations (1)

75013

AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM, Paris

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT03597659 - PheWAS of a Polygenic Predictor of Thyroid Function | Biotech Hunter | Biotech Hunter